Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

What does AstraZeneca look for in a licensing partner?

What does AstraZeneca look for in a licensing partner? We asked AstraZeneca’s VP of Strategic Partnering & Business Development. Are you curious to find out more about what pharma companies look for in a licensing partner? Shaun Grady...

Articles

Adherence - the bridge between clinical and real world outco...

Adherence is not just a problem to be addressed once a drug has launched, but a pivotal factor in determining outcomes, which makes it a key part of the value proposition for market access. Whilst the term ‘market access’ is well used within pharma, it does mean different things to different people. Historically, it has focussed on the payer alone and negotiating…

Articles

Executive perspectives: Cavan Redmond

WebMD leads the way when it comes to digital health information, so pharmaphorum caught up with its CEO, Cavan Redmond, to hear where online healthcare is heading. Health has been a popular topic on the internet since its very earliest days, with research showing that around 80% of web users search for information relating to…

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital